The listed arm of Sanjiu Enterprises, China's largest pharmaceutical group, has been fined Yn500,000 and its directors between Yn30,000 and Yn100,000 each for failing to disclose information, South China Morning Post said. A routine investigation by the China Securities Regulatory Commission last year found Shenzhen-listed Sanjiu Medical and Pharmaceutical had not disclosed large transactions with its parent, its profits from investing in the stock market through its parent company, or the deposit of Yn1.14bn into related company Shenzhen Financial Leasing.
Sanjiu Enterprises was formerly owned by the People's Liberation Army.